拓新药业：第三季度净利润亏损1188.05万元，下降1,258.62%

Core Viewpoint - The company reported a significant decline in both revenue and net profit for the third quarter and the first three quarters of the year, indicating financial challenges ahead [1] Financial Performance - The third quarter revenue was 89.65 million yuan, a decrease of 16.21% compared to the previous period [1] - The net profit for the third quarter was a loss of 11.88 million yuan, representing a drastic decline of 1,258.62% [1] - For the first three quarters, the total revenue was 272 million yuan, down 16.64% year-on-year [1] - The net profit for the first three quarters was a loss of 30.16 million yuan, reflecting a decline of 1,036.53% [1]